Nature Biotechnology

A monthly journal covering the science and business of biotechnology, with new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences.

More about the journal

The Pandemic Pipeline

Editor

From the Editors, COVID-19

The Pandemic Pipeline

Brady Huggett

Mar 23, 2020

Nature Biotechnology

Behind the Paper

Improving the versatility of CRISPR genome editing using a hybrid approach. By Jason Moffat

CHyMErA - a new CRISPR-based tool allows simultaneous genome editing at multiple sites to learn how different genomic sites and DNA stretches co-operate in health and disease.

Jason

Mar 17, 2020

Using CRISPR to develop superior corn hybrids

Nature Biotechnology

Behind the Paper

Using CRISPR to develop superior corn hybrids

N. Doane Chilcoat

Mar 09, 2020

ChromID identifies the protein interactome at chromatin marks

Nature Biotechnology

Behind the Paper

ChromID identifies the protein interactome at chromatin marks

Rodrigo Villaseñor

Mar 02, 2020

Controlling the microenvironment to make β cells from human stem cells for diabetes regenerative therapy

Nature Biotechnology

Behind the Paper

Controlling the microenvironment to make β cells from human stem cells for diabetes regenerative therapy

Jeffrey R. Millman

Feb 24, 2020

Targeted nanopore sequencing with Cas9-guided adapter ligation

Nature Biotechnology

Behind the Paper

Targeted nanopore sequencing with Cas9-guided adapter ligation

Timothy 'Gilfunk' Gilpatrick

Feb 13, 2020

Closing bacterial genomes from the human gut microbiome using long-read sequencing

Nature Biotechnology

Behind the Paper

Closing bacterial genomes from the human gut microbiome using long-read sequencing

Dylan Maghini

Feb 12, 2020

Evolution of Gene Therapy products : promising non-viral vector prospects from innovation patents

Nature Biotechnology

Behind the Paper

Evolution of Gene Therapy products : promising non-viral vector prospects from innovation patents

Marxa L Figueiredo

Feb 07, 2020

Phosphoprotein signatures and computational approaches reconstruct patient-specific kinase network topologies

Nature Biotechnology

Behind the Paper

Phosphoprotein signatures and computational approaches reconstruct patient-specific kinase network topologies

Maruan Hijazi Vega

Jan 21, 2020

Engineering a machine to keep livers alive for one week outside of the body

Nature Biotechnology

Behind the Paper

Engineering a machine to keep livers alive for one week outside of the body

Dilmurod Eshmuminov

Jan 13, 2020

Benchmarking, Simulations and Tumour Evolution

Nature Biotechnology

Behind the Paper

Benchmarking, Simulations and Tumour Evolution

Dr. Paul C. Boutros

Jan 09, 2020

First Rounders: Greg Verdine

Editor

Nature Biotechnology

From the Editors

First Rounders: Greg Verdine

Brady Huggett

Jan 02, 2020

Efficient, continuous mutagenesis in human cells using a pseudo-random DNA editor

Nature Biotechnology

Behind the Paper

Efficient, continuous mutagenesis in human cells using a pseudo-random DNA editor

Sophia Liu

Dec 17, 2019

Nanopores for single amino acid electrical recognition towards protein sequencing

Nature Biotechnology

Behind the Paper

Nanopores for single amino acid electrical recognition towards protein sequencing

Hadjer Ouldali

Dec 17, 2019

Turning a yeast species into an autotroph

Nature Biotechnology

Behind the Paper

Turning a yeast species into an autotroph

Thomas Gassler

Dec 16, 2019

Nature Biotechnology

Behind the Paper

Harnessing the intracellular triacylglycerols for titer improvement of polyketides in Streptomyces

Pharmaceutically important polyketides are produced during the stationary phase of growth of Streptomyces species in fermenters. The source of intracellular metabolites that are funneled into polyketide biosynthesis has proven elusive. We uncover the mystery and devised a titer improvement strategy.